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Abstract
Background: The incidence of neurological complications and fatalities associated with Hand, Foot & Mouth
disease has increased over recent years, due to emergence of newly-evolved strains of Enterovirus 71 (EV71). In the
search for new antiviral therapeutics against EV71, accurate and sensitive in vitro cellular models for preliminary
studies of EV71 pathogenesis is an essential prerequisite, before progressing to expensive and time-consuming live
animal studies and clinical trials.
Methods: This study thus investigated whether neural lineages derived from pluripotent human embryonic stem
cells (hESC) can fulfil this purpose. EV71 infection of hESC-derived neural stem cells (NSC) and mature neurons (MN)
was carried out in vitro, in comparison with RD and SH-SY5Y cell lines.
Results: Upon assessment of post-infection survivability and EV71 production by the various types, it was observed
that NSC were significantly more susceptible to EV71 infection compared to MN, RD (rhabdomyosarcoma) and SH-
SY5Y cells, which was consistent with previous studies on mice. The SP81 peptide had significantly greater
inhibitory effect on EV71 production by NSC and MN compared to the cancer-derived RD and SH-SY5Y cell lines.
Conclusions: Hence, this study demonstrates that hESC-derived neural lineages can be utilized as in vitro models
for studying EV71 pathogenesis and for screening of antiviral therapeutics.
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Background
Enterovirus 71 (EV71), the causative agent of Hand, Foot
& Mouth disease (HFMD), is a single-stranded positive-
sense RNA virus [1]. The clinical symptoms of HFMD is
often mild, manifested by fever with papulovesicular
rash on the soles and palms [2]. However, in recent
years, new virulent strains of EV71 have evolved, with
the potential to cause severe neurological complications
and even fatalities in young children below six years of
age [3, 4]. Currently, effective treatment modalities
against such new strains of EV71 is lacking, and there is
therefore an urgent and dire need to develop new anti-
viral therapeutics against EV71.
In the research and development pipeline, accurate
and sensitive in vitro cellular models for investigating
EV71 pathogenesis are of paramount importance in the
preliminary screening and testing of newly-developed
antiviral agents, before progressing to expensive and
time-consuming in vivo animal studies, followed by clin-
ical trials in human patients. Currently, various immor-
talized cell lines derived from cancers such as RD and
Vero cells are widely utilized for in vitro studies of EV71
[5, 6]. RD cells are derived from human rhabdomyosar-
coma [7], while Vero cells are derived from the kidney
epithelium of African green monkeys [8]. There are
some deficiencies in utilizing these cells for in vitro
modelling of EV71 pathogenesis. In particular, there are
inherent genetic abnormalities and karyotypic instability
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of these cells due to their neoplastic origin [9], which
would poorly reflect normal human physiology in vivo.
It is imperative for in vitro cellular models to closely
mimic physiological conditions so as to provide a realis-
tic picture of in vivo cellular interactions with infectious
agents such as EV71.
Another major deficiency is that commonly-utilized
cell lines for studying EV71 such as RD and Vero
cells do not express the neural phenotype required to
model neurological complications associated with
HMFD, which often lead to fatalities in young chil-
dren [3, 4]. For example, mature neurons of the cen-
tral nervous system are mitotically quiescent and have
unique electrophysiological properties not displayed
by fast-proliferating RD and Vero cells. One solution
may be to utilize neural tissues derived from labora-
tory animals or explanted from human cadavers,
abortuses [10] and discarded pathological waste sam-
ples from brain and spinal cord surgery. Nevertheless,
these alternative sources of neural tissues for in vitro
studies also have their limitations. In particular, neu-
rons from animal species may exhibit different elec-
trophysiological properties to human neurons [11],
and there is often scarce supply of neural tissues ob-
tained from human cadavers, abortuses and discarded
surgical waste, in addition to much inter-batch vari-
ability depending on the medical condition and age of
the human donors. Moreover, it must be remembered
that the proliferative capacity and in vitro lifespan of
primary neural tissue cultures are also very much
limited.
These limitations and deficiencies may be overcome by
utilizing human neural lineages differentiated from human
embryonic stem cells (hESCs) [12, 13], which are isolated
from blastocyst-stage embryos [14, 15]. Unlike immortal-
ized cancer-derived cell lines such as RD and Vero cells,
most hESCs and their differentiated neural progenies are
karyotypically stable and genetically normal [16, 17]. Com-
pared to animal-derived neural explants, hESC-derived
neural lineages are more representative of human central
nervous system (CNS) physiology and may more accur-
ately recapitulate the in vivo interaction between EV71
and the human CNS during pathogenesis, hence overcom-
ing the problem of species-specificity. Due to the
unlimited proliferative and self-renewal capacity of hESCs
[14, 15], the problems of scarce supply, short lifespan and
senescence associated with primary explanted human
neural tissue cultures can therefore be avoided by obtain-
ing neural lineages from hESCs. Moreover, efficient in
vitro differentiation protocols for deriving neural lineages
from hESCs have now been developed [18, 19], and vari-
ous studies have also validated the excellent neural pheno-
type and electrophysiological properties displayed by these
cells [20, 21].
All these advantages of hESC-derived neural lineages
for in vitro studies have in turn led to their increasing
adoption by neuroscience researchers for pathological
modelling of neurodegenerative diseases, toxicology as-
sessment, and drug screening [22]. However, the poten-
tial use of these cells for in vitro modelling of the
pathogenesis of infectious diseases targeting the nervous
system, such as EV71, has been much less studied.
This study will utilize EV71 strain 41, which was ori-
ginally isolated from a fatal case of encephalitis during a
major HMFD outbreak in Singapore in the year 2000
[23]. Previously, this particular EV71 strain was studied
with AG129 strain mice that lacked alpha/beta-inter-
feron and gamma-interferon receptor genes [24]. The
objective of this study is to investigate EV71 infection of
hESC-derived mature neurons and neural stem cells in
vitro, in comparison with RD cells that is commonly-
utilized for EV71 studies [5], as well as with a
neuroblastoma-derived cell line SH-SY5Y [25]. Cell sur-
vivability after infection and EV71 replication will be
assessed and compared amongst these four different cell
types. Additionally, the inhibitory effect of SP81 peptide
on EV71 replication, which was reported in a previous
study [26], will also be compared amongst the four dif-
ferent cell types. The results obtained will be used to
evaluate whether hESC-derived mature neurons and
neural stem cells are suitable in vitro cellular models for
studying EV71 pathogenesis.
Methods
Cells, viruses, reagents, culture media, and other
consumables
The hESC line WA01 was purchased from Wicell
Institute Inc. (Madison, WI, USA). RD cells and SH-
SY5Y cells were purchased from the American Type
Culture Collection (ATCC, Manassas, VA, USA). Un-
less otherwise stated, all chemical reagents (analytical
grade) were purchased from Sigma-Aldrich Inc. (St.
Louis, MO, USA), all plastic labware consumables
were purchased from Becton-Dickinson Inc. (Franklin
Lakes, NJ, USA), and all cell-culture media, supple-
ments, coatings, serum, and serum supplements were
purchased from Life Technologies Inc. (Carlsbad, CA,
USA). Stocks of EV71 strain 41 (5865/SIN/000009)
(GenBank accession number: AF316321) were ob-
tained through propagation in RD cells with DMEM
supplemented with 2 % FBS. SP81 peptide based on
the VP1 capsid protein of EV71 was synthesized by
Mimotopes Pty Ltd. (Clayton Victoria, Australia), with
a 95 % HPLC purity grade. This peptide was reconsti-
tuted in 100 % dimethyl sulfoxide (DMSO) and stored
at −80 °C, prior to being diluted and utilized for
experimental study.
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Cell culture and expansion
The hESC line WA01 was routinely cultured on
Geltrex™ (Cat No. A15696-01, Life Technologies Inc.)
pre-coated 6-well culture plates with mTeSR1™ medium
(Cat No. 05850, Stem Cell Technologies Inc., Vancouver,
BC, Canada). Upon reaching confluence after 5 to 7 days
of culture, serial passage was carried out with enzymatic
dissociation of colonies into cellular clumps with 1 mg/
ml of collagenase. The RD cells and SH-SY5Y cells were
routinely cultured in T75 cell culture flasks in culture
milieu comprising of Dulbecco’s Minimum Essential
medium (DMEM), supplemented with 10 % (v/v) fetal
bovine serum (FBS) and 1 % (v/v) penicillin strepto-
mycin antibiotic solution. When cultures became conflu-
ent after 5–7 days of culture, serial passage at a split
ratio of 1:4 to 1:5 was carried out through enzymatic
dissociation with 0.05 % Trypsin–EDTA solution. All
cell cultures were maintained within a 5 % CO2 incuba-
tor at 37 °C.
Induction of human embryonic stem cells into neural
stem cells
Confluent hESC cultures were dissociated into cellular
clumps with 1 mg/ml collagenase, washed once with
phosphate buffered saline (PBS) through centrifugation
and then digested into a single cell suspension through
treatment with StemPro™ Accutase Cell Dissociation Re-
agent (Cat. no. A11105, Life Technologies Inc.), for 5 to
10 min followed with gentle pipetting. The dissociated
hESC were then reconstituted in mTeSR1™ medium sup-
plemented with 10 μM ROCK Inhibitor Y27632 (Cat.
no. Y0503, Sigma-Aldrich Inc.), and plated into 6-well
culture plates pre-coated with Geltrex™, at a density of
2.5 × 105–3 × 105 cells per well. The following day, in-
duction of hESC into NSC was carried out by replacing
the culture milieu with Neurobasal™ medium (Cat No.
21103-049, Life Technologies Inc.) supplemented with
2 % (v/v) Neural Induction Supplement™ (Cat No.
A16477-01, Life Technologies Inc.) and 1 %(v/v)
penicillin-streptomycin antibiotic solution. Cultures be-
came confluent after 6 to 7 days of culture in a 5 % CO2
incubator set at 37 °C, and were serially passaged onto
Geltrex™ pre-coated 6-well plates with StemPro Accutase
Cell Dissociation Reagent™, utilizing similar aforemen-
tioned seeding densities. NSC from the third passage on-
wards were utilized for differentiation into mature
neurons, as well as for further experiments.
Induction of neural stem cells into mature neurons
NSC cultures were dissociated into a single cell suspen-
sion with StemPro™ Accutase Cell Dissociation Reagent,
washed once in PBS through centrifugation, and then
seeded on 6 or 24-well culture plates pre-coated with
Poly-L-Ornithine (10 μg/ml) and Laminin (20 μg/ml) at
a seeding density of 2.5–5 × 104 cells/cm2, in complete
StemPro™ NSC SFM (serum-free medium) comprised of
KnockOut™ D-MEM/F-12 (Cat. No. 12660, Life Tech-
nologies Inc.), supplemented with 2 % (v/v) StemPro™
Neural Supplement (Cat. No. A1050801, Life Technolo-
gies Inc.), 20 ng/ml EGF (Cat. No. PHG0314, Life Tech-
nologies Inc.), 20 ng/nl bFGF (Cat. No. PHG0024, Life
Technologies Inc.), 2 mM (L-glutamine), and 1 % (v/v)
penicillin-streptomycin antibiotic solution. After 2 days
of culture in StemProTM™ NSC SFM, the medium was
changed to neural differentiation medium, comprised of
Neurobasal™ medium supplemented with 2 % (v/v) B-
27™ Serum-Free Supplement, 2 mM L-glutamine and
1 % (v/v) penicillin-streptomycin antibiotic solution.
Fresh neural differentiation medium was replaced every
3–4 days. From day 7 onwards, 0.5 mM of dibutyryl
cAMP (Cat. No. D0627, Sigma-Aldrich Inc.) was added
to the neural differentiation medium daily, to expedite
differentiation into mature neurons (MN). After 10 days
of differentiation culture, the mature neurons obtained
were utilized for further experiments.
Differentiation of SH-SY5Y cells
SH-SY5Y cells were seeded onto 6 or 24-well culture
plates at a density of 3 × 103 to 1 × 105 cells/cm2 with
DMEM supplemented with 10 % (v/v) FBS and 1 % (v/v)
penicillin streptomycin antibiotic solution. The following
day, serum-containing medium was replaced with Neu-
robasal™ medium supplemented with 2 % (v/v) B-27™
Serum-Free Supplement, 2 mM L-glutamine, 10 μM all-
trans-retinoic acid, and 1 % (v/v) penicillin-streptomycin
antibiotic solution, to promote differentiation and neur-
onal phenotype. SH-SY5Y cells were cultured for 10 days
under differentiation conditions, prior to being utilized
for further experiments.
Immunocytochemistry for detection of neural markers
After neural induction and differentiation, NSC and MN
were fixed with 4 % (v/v) paraformaldehyde for 15 min,
permeabilized with 0.1 % Triton X-100 for 10 min, and
then blocked in PBS supplemented with 10 % (v/v) FBS
for 2 h. The fixed cells were then incubated for 2 h at
room temperature with the appropriate primary anti-
bodies: anti-doublecortin antibody (Cat. No. sc-271390,
Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA),
and anti-nestin antibody (Cat. No. sc-23927, Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA) diluted in 1 %
(w/v) BSA/PBS at appropriate concentrations. The cells
were then washed in 1 % BSA/PBS and incubated in the
dark with the appropriate secondary antibodies: Goat
anti-Mouse IgG FITC-conjugated (Cat. No. sc-2010,
Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA)
and Goat anti-Mouse IgG PE-conjugated (Cat. No. sc-
358926, Santa Cruz Biotechnology Inc., Santa Cruz, CA,
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USA) for 2 h at room temperature. The secondary anti-
bodies were diluted in 1 % BSA/PBS at appropriate con-
centrations. Following another wash with 1 % (w/v) BSA/
PBS, the cell nuclei were stained with DAPI, prior to im-
aging under a Nikon Eclipse Ti™ fluorescent microscope
with the appropriate excitation/emission wavelength.
qRT-PCR analysis of neural marker expression
Quantitative real-time RT-polymerase chain reaction
(qRT-PCR) analysis of neural marker gene expression
was carried out as described previously [27]. Briefly,
RNA from undifferentiated hESC (WA01), NSC, MN,
RD and SH-SY5Y cells were harvested using the Innu-
PREP™ RNA mini kit 86 (Cat No. 845-ks-1040050,
Analytik Jena GmbH, Jena, Germany) with DNase treat-
ment. cDNA was synthesized from the extracted RNA
using the high capacity cDNA reverse transcriptase kit
(Cat. No. 4374966, Applied Biosystems Inc, Carlsbad,
CA, USA). qRT-PCR analysis was then performed with a
Biorad C1000 Touch™ thermal cycler (Bio-Rad Labora-
tories, Hercules, CA, USA), utilizing SYBR Green™ Mas-
termix (Cat No. 4367659, Life Technologies Inc.,
Carlsbad, CA, USA) with appropriate custom-designed
primers for early neural markers: Pax6, Musashi1 and
βIII-tubulin, and mature neural markers: MAP2 (Micro-
tuble Associated Protein 2), NCAM (Neural Cell
Adhesion Molecule), NFM (Neural Filament Protein -
Medium) and NSE (Neural Specific Enolase), as
previously described [27]. The following amplification
parameters were utilized for qRT-PCR: two minutes at
50 °C, 20 s at 95 °C, and 60 cycles of 1 s at 95 °C,
followed by one minute at 60 °C. The relative Cycle
Threshold (Ct) was determined and normalized against
the endogenous GAPDH housekeeping gene. The fold
change of each gene was compared against either undif-
ferentiated hESC or NSC. All bar charts and graphs
show standard deviations representing at least three ex-
perimental replicates.
Infection of different cell types with EV71 and inhibition
of viral replication with SP81 peptide
NSC, MN, RD and SH-SY5Y cells were seeded in 24
well-plates at a density of 4.0 X 105 cells per well over-
night. The following day, cell counts (hemocytometer)
were performed on trypsin-dissociated cells from two to
three representative wells for each cell type, because the
cell number in each well would be expected to change
due to proliferation and apoptosis during the seeding
process. For each of the four different cell types, some of
the wells were treated for 1 h with 100 μM of the SP81
peptide reconstituted in serum-free medium, while other
wells were left untreated. The four different cell types
were then infected with diluted stocks of EV71 in
serum-free medium, at a constant Multiplicity of
Infection (MOI) of 0.1. After adsorption for 1 h, the in-
oculum was removed, and the cells were washed twice
with the serum-free medium, prior to replacement of
the appropriate maintenance medium for each of the
four different cell types. Altogether, there were three ex-
perimental groups for each different cell type: (i) un-
treated control, (ii) treated with EV71 only, and (iii)
treated with both SP81 peptide and EV71. Cell culture
supernatants were harvested at the 24-, 72- & 120-h
post-infection timepoints, for all four different cell types
and three treatment groups, for quantification of viral
copy number via qRT-PCR assay.
Assessment of cell survivability after infection with EV71,
with and without pre-treatment with SP81 peptide
Cell survivability after exposure to the SP81 peptide and
EV71, were assessed with the CellTiter-Blue™ cell viabil-
ity assay (Promega Inc., Madison, WI, USA), according
to the manufacturer’s instructions. This assay is based
on change in fluorescent properties upon the reduction
of resazurin (Alamar Blue) to resorufin by metabolically-
active viable cells [28]. At the 24 h and 120 h timepoints,
untreated cells and cells treated with SP81 and/or EV71,
were washed three times in PBS, prior to the addition of
50 μl of CellTiter-Blue™ solution in 200 μl of culture
media within each well of the 24-well culture plate. After
incubation for 2 to 3 h at 37 °C within a 5 % CO2 incu-
bator, 200 μl aliquots of the reaction mixture were trans-
ferred onto a fresh 96-well plate, and fluorescence
readings were measured spectrophotometrically at an
excitation/emission wavelength of 560/590 nm respect-
ively, utilizing a Tecan infinite M200 Pro™ microplate
reader (Tecan Inc., Maennedorf, Switzerland). The cell
viability after exposure to SP81 peptide and/or EV71,
was calculated as the ratio of fluorescence readings
(560/590 nm) yielded by the treated and untreated wells,
after correction for blank fluorescence reading of the re-
action mixture incubated without cells for the same dur-
ation (2 to 3 h) at 37 °C.
Reverse Transcription (RT) TaqMan Real-time PCR Assay
for determination of virus copy number in cell culture
supernatants
The primers and probe were designed according to Tan et
al. [26]. The forward primer employed was 59-
GAGCTCTATAGGAGATAGTGTGAGTAGGG-39, the
reverse primer was 59-ATGACTGCTCACCTGCGTGT
T-39 and the TaqMan™ probe used was 596-FAM-
ACTTACCCA/ZEN/GGCCCTGCCAGCTCC lowa Black
FQ-39 (Applied Biosystems Inc., Carlsbad, USA). The viral
RNA samples were extracted from the collected cell cul-
ture supernatants (Days 1, 3 and 5 post-infection) using
the QIAamp™ Viral RNA mini kit (QIAGEN, Hilden,
Germany) according to the manufacturer’s instructions.
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The RT TaqMan real-time PCR assay was performed with
the Biorad C1000 Touch™ thermal cycler (Bio-Rad La-
boratories, Hercules, CA, USA) using TaqMan™ Fast virus
1-step master mix (Applied Biosystems Inc., Carlsbad,
USA) with cDNA synthesis by reverse transcription for
5 min at 50 °C and subsequent amplification for 40 cycles
at 95 °C for 3 s, 60 °C for 30 s.
Statistical analysis of data
All bar charts and graphs show standard deviations
representing at least three replicate measurements. Ether
the Chi-squared test or Student’s t-test were carried out
to determine whether observed differences were statisti-
cally significant between different experimental condi-
tions (P < 0.05 was considered statistically significant).
Results
Induction of human embryonic stem cells into neural
stem cells, followed by differentiation into mature
neurons
Immunocytochemistry and qRT-PCR analysis of neural
marker expression, was utilized to validate the NSC and
MN populations obtained from hESC differentiation. As
seen in the immunocytochemistry results presented in
Fig. 1, there is positive expression of Nestin, a neural stem
cell marker [29] by the NSC population derived from the
hESC WA01 line in this study. Likewise, positive expression
of Doublecortin, a mature neural marker [30], was also de-
tected in the hESC-derived MN population. The qRT-PCR
results (Fig. 2a) showed significant upregulation of early
neural differentiation markers: PAX6, Musashi1 and βIII-
tubulin [31–33] upon induction of hESC into NSC (9772.4,
15203.4 & 2329.0-folds respectively with respect to (w.r.t)
hESC, P < 0.05), followed by a significant downregulation
upon differentiation of NSC into MN (2.1, 8.3 & 0.6-folds
respectively w.r.t hESC, P < 0.05). The RD and SH-SY5Y
cells displayed much higher expression of all three early
neural markers, as compared to undifferentiated hESC
(after normalization with housekeeping gene GAPDH ex-
pression). The fold-differences in expression levels of
PAX6, Musashi1 and βIII-tubulin by RD cells w.r.t. hESC
were 25.0, 3.6 & 46.9 respectively, while the corresponding
fold-differences in expression of these gene by SH-SY5Y
cells were 62.8, 129.8 & 152.0 respectively. As seen in
Fig. 1 Immunostaining of (a) neural stem cells (NSC) for expression of Nestin, and (b) mature neurons (MN) for expression of Doublecortin. c and
d are the corresponding phase-contrast light microscopy images of (a) and (b) respectively. e and f are the corresponding DAPI-stained images
(nuclear DNA) of (a) and (b) respectively
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Fig. 2b, qRT-PCR analysis of mature neural marker expres-
sion: MAP2, NCAM, NFM & NSE [34–37] showed signifi-
cant upregulation of these marker genes upon
differentiation of NSC to MN (99.0, 624782.3, 86.5 & 22.0-
folds respectively w.r.t. NSC, P < 0.05). SH-SY5Y cells dis-
played elevated expression of all four marker genes: MAP2,
NCAM, NFM & NSE compared to NSC, after
normalization with GAPDH (303.3, 15343.5, 72.6 & 18.5-
folds w.r.t. NSC respectively). By contrast, RD cells
displayed elevated expression of only NCAM and NFM
compared to NSC (816211 and 190.5-folds w.r.t NSC re-
spectively), while expression of MAP2 and NSE were much
lower than that of NSC (7.2 X 10−6 and 3.0 X 10−4-folds
w.r.t NSC respectively).
Cell survivability after infection with EV71, with and
without pre-treatment with SP81 peptide
The CellTiter-Blue™ assay based on resazurin (Alamar
Blue) was used to assess survivability of NSC, MN, RD
and SH-SY5Y cells at 1 & 5 days after infection with
EV71, with and without pre-treatment with SP81 pep-
tide. The results (Fig. 3) showed that with the exception
of SH-SY5Y cells that displayed minimal cell death after
EV71 infection, all the other cell types (NSC, MN & RD
cells) displayed substantial loss of viability upon infec-
tion with EV71. Moreover, it was observed that with the
exception of SH-SY5Y cells, pre-treatment with the SP81
peptide had significant effects in improving survivability
of all other cell types (NSC, MN & RD cells), at either
or both the 1 & 5 days post-EV71 infection time-points.
At the 1 day time-point, the viability of NSC, MN & RD
cells, without SP81 peptide pre-treatment were 70.4 ±
6.6 %, 82.5 ± 6.8 % & 54.6 ± 2.8 % respectively, as op-
posed to 93.0 ± 5.1 % for SH-SY5Y cells. With SP81 pep-
tide pre-treatment, the viability of NSC and RD cells at
the 1 day post-infection time-point were significantly
increased to 97.1 ± 4.1 % and 77.2 ± 1.5 % respectively
(P < 0.05); whereas the corresponding viability of MN
Fig. 2 qRT-PCR analysis of the expression of (a) early neural differentiation markers, and (b) mature neural differentiation markers by hESC, NSC,
MN, RD and SH-SY5Y cells. *, ^, ×, †, ‡, • : Significantly different at P < 0.05 (Student’s t-test)
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and SH-SY5Y cells were not significantly changed (82.0
± 2.3 % and 96.7 ± 4.4 % respectively, P > 0.05) by SP81
peptide pre-treatment. At the 5 day time-point, the via-
bility of NSC, MN & RD cells, without SP81 peptide
pre-treatment were 0.5 ± 0.1 %, 23.4 ± 4.9 % & 18.7 ±
0.2 % respectively, as opposed to 89.8 ± 4.7 % for SH-
SY5Y cells. With SP81 peptide pre-treatment, the viabil-
ity of NSC and MN cells at the 5 days post-infection
time-point were significantly increased to 71.3 ± 9.5 %
and 54.7 ± 2.6 % respectively (P < 0.05); whereas the cor-
responding viability of RD and SH-SY5Y cells were not
significantly changed (18.9 ± 2.2 % and 96.2 ± 6.3 % re-
spectively, P > 0.05) by SP81 peptide pre-treatment.
qRT-PCR analysis of EV71 replication in the various cell
types, with and without pre-treatment with SP81 peptide
As seen in Fig. 4a, qRT-PCR analysis showed that the in-
fected NSC yielded the highest level of EV71 replication,
with a viral copy number of 4336.7 ± 1573.1 per 1000 in-
fected cells. This was significantly higher than the corre-
sponding values obtained for MN, RD and SH-SY5Y
cells (205.1 ± 128.7, 142.6 ± 35.2 and 45.6 ± 20.5 respect-
ively, P < 0.05). Upon pre-treatment with SP81 peptide,
NSC exhibited the highest % inhibition of EV71 replica-
tion (computed as the percentage reduction in viral copy
number) of 93.2 ± 1.2 %, which was significantly higher
than the corresponding values obtained for MN, RD and
SH-SY5Y cells (74.7 ± 8.4 %, 33.2 ± 7.3 % and 51.7 ±
7.6 % respectively, P < 0.05).
Discussion
This study derived NSC and MN from undifferentiated
hESC and utilized these cells for modelling EV71 patho-
genesis in vitro, in comparison to cancer-derived RD
and SH-SY5Y cell lines [7, 25]. Prior to utilizing these
cells for in vitro studies with EV71, it was imperative to
characterize and validate the neural phenotype of these
cells with immunocytochemistry and qRT-PCR. Consist-
ent with the scientific literature [29, 30], Nestin and
Doublecortin were positively expressed by NSC and MN
respectively (Fig. 1). The qRT-PCR data (Fig. 2a) showed
strong upregulation of early neural differentiation
markers (PAX6, Musashi1, & βIII-tubulin) upon induc-
tion of undifferentiated hESC into NSC, followed by a
sharp downregulation of these genes upon further differ-
entiation of NSC into MN, which is consistent with their
known function [31–33]. By contrast, there was a strong
upregulation of mature neural differentiation markers
(MAP2, NCAM, NFM & NSE) during the transition of
NSC to MN, which is again consistent with the scientific
literature [34–37]. Hence, these data validated the neural
phenotype of the MN and NSC populations.
The relatively high expression of both early and ma-
ture neural differentiation markers by SH-SY5Y cells is
Fig. 3 Viability of NSC, MN, RD and SH-SY5Y cells, after 1 and 5 days
exposure to EV71, with or without prior treatment with SP81 peptide
(CellTiter-Blue™ assay). *, ^, ×, † : Significantly different at P < 0.05
(Chi-squared test)
Fig. 4 . qRT-PCR analysis of (a) EV71 production by NSC, MN, RD
and SH-SY5Y cells over 5 days of culture. b SP81 peptide inhibition
of EV71 replication in NSC, MN, RD and SH-SY5Y cells over 5 days of
culture. Results of all experimental groups were significantly from
each other, unless otherwise indicated. * : Not significantly different
at P > 0.05 (Student’s t-test)
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expected, given its origin from neuroblastoma [25], and
that these cells have been subjected to neural differenti-
ation for 10 days in the presence of retinoic acid [38].
Interestingly, it was found that RD cells of smooth
muscle rhabdomyosarcoma origin [7] displayed relatively
high expression of both early neural differentiation
markers: (PAX6, Musashi1, & βIII-tubulin (Fig. 2a), as
well as the mature neural differentiation markers NCAM
and NSE (Fig. 2b). This appears to be consistent with
previous studies that reported expression of neural
markers by skeletal muscle tumors [39–41]. For ex-
ample, Miettinen and Rapola [39] found that rhabmyo-
sarcoma and rhabmyosarcoma-like tumors from a wide
range of patients exhibited immunoreactivity to NFM
protein, while Molenaar and Muntinghe [40] reported
that the expression of NCAM and NFM isoforms were
widely expressed by skeletal muscle tumors. Similarly,
Soler et al. [41] also reported that Rhabmyosarcoma-
derived cell lines displayed aberrant expression of
various neural attachment proteins such as NCAM and
N-Cadherin. This may suggest that RD cells could be
suitable in some ways for modelling neurological com-
plications associated with EV71 infection, since these
cells also express various neural markers.
Subsequently, NSC and MN, together with RD and
SH-SY5Y cells were utilized for in vitro studies with
EV71. Assessment of cell viability after EV71 infection
showed that SH-SY5Y cells exhibited the highest, and
NSC the lowest post-infection survivability amongst the
4 different cell types. The observed much higher suscep-
tibility of NSC to EV71 infection as compared to MN
and SH-SY5Y cells (that have been differentiated with
retinoic acid), is consistent with the study of Huang et
al. [42], which showed that mice neural progenitor cells
are much more susceptible to EV71 infection, as com-
pared to mature neural lineages. Similar results were
also reported by another study on mice [43], which
showed that the closely-related Coxsackie virus of the
genus Enterovirus, specifically targets fast-proliferating
neural progenitor cells of the neonatal central nervous
system. Hence, our in vitro data on human NSC and
MN (derived from hESC), therefore validates the results
of previous studies on the murine model [42, 43].
In the previous study of Tan et al. [26], the protective
effects of a number of potential antiviral peptides against
EV71 was assessed and compared; and it was shown that
the SP40 peptide had a more potent antiviral effect
against EV71, as compared to the SP81 peptide. Never-
theless, this study chose to examine SP81 instead of
SP40, precisely because its lesser potency would enable a
better assessment of the sensitivity of our in vitro cell
culture model for screening antiviral agents. Pre-
treatment with SP81 peptide seemed to exert an insig-
nificant effect on the already high post-infection
survivability of SH-SY5Y cells, in contrast to the sharp
increase in post-infection survivability observed with
NSC pre-treated with this peptide. Interestingly, it was
observed that the SP81 peptide significantly improved
the post-infection survival rates of NSC and RD cells on
day 1, while there was no significant improvement in the
case of MN. By contrast, 5 days after infection, it was
observed that SP81 peptide had a significant protective
effect on the post-infection survivability of MN. This is
hypothesized to be due to differences in the mitotic rate
of MN versus NSC and RD cells. Previous studies on the
closely-related Coxsackie virus of the genus Enterovirus,
have demonstrated that faster proliferating cells are
much more susceptible to viral infection, as compared
to mitotically quiescent cells [44, 45]. Because MN
would be expected to be much less mitotically active
compared to RD and NSC, EV71 infection of MN would
presumably take place much more slowly. Hence, the
protective effect of the SP81 peptide on MN survivability
is not apparent on day 1, but became apparent after
5 days post-infection (Fig. 3).
qRT-PCR analysis of EV71 production by the various
cell types over 5 days of culture (Fig. 4a) showed that
NSC produced the highest yield of virus within the cell
culture supernantant that was significantly higher than
MN. Again, this is consistent with aforementioned previ-
ous studies in mice that demonstrated the greater sus-
ceptibility of neural progenitors to enterovirus compared
to mature neural lineages [42, 43]. Rhoades et al. [46]
hypothesized that neurotropic enteroviruses such as
EV71 evolved to specifically target neural progenitors
and stem cells (NPSCs) within the central nervous sys-
tem, as this facilitates viral tropism and transmission.
Because NPSCs actively proliferate during neonatal de-
velopment, as well as occasionally during adult life, in-
fection of NPSCs rather than mitotically-inactive mature
neural lineages would thus expand the tropism of en-
teroviruses. Moreover, the ability of NPSCs to migrate as
they differentiate and give rise to mature neural lineages
would also maximize the transmission of enteroviruses
throughout the entire central nervous system. Specific
targeting of NPSCs by enterovirus might also be a strat-
egy to establish persistent infection with sporadic reacti-
vation whenever quiescent NPSCs are activated to give
rise to mature neural lineages. Clinical symptoms of
HFMD-associated neurological complications are more
frequently manifested in young children and infants than
mature adults [3, 4]. It is hypothesized that this could be
due to more mitotically-active neural progenitors being
present in their central nervous system compared to
adults, which in turn makes them more susceptible to
EV71 infection. Indeed, our results which showed higher
EV71 copy number in NSC versus MN cells is consistent
with this hypothesis.
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Interestingly, it was observed that although the cell via-
bility of SH-SY5Y cells was quite resistant to EV71 infec-
tion (Fig. 3), a substantial amount of virus was detected in
the cell culture supernatant with qRT-PCR, even though
this was still the lowest amongst the four different cell
types (Fig. 4a). The results observed for SH-SY5Y cells are
surprising considering that these cells are of human neural
origin (neuroblastoma), have a relatively high mitotic rate,
and display relatively enhanced expression of early/mature
neural differentiation markers [25]. Apoptosis in mamma-
lian cells is readily triggered by viral infection, which
serves as a naturally-evolved host defense mechanism
against pathogenic viruses [47]. Nevertheless, it must be
remembered that the apoptotic machinery in cancer-
derived immortalized cell lines like SH-SY5Y is highly-
deficient, making these cells much more robust, and
enabling them to maintain their viability in the face of se-
vere environmental insults or stress factors that would
normally trigger apoptosis in normal primary somatic cells
of non-cancerous origin.
Subsequent analysis of the inhibitory effect of SP81
peptide on EV71 production by the four different cell
types showed that NSC and MC exhibited significantly
higher levels of inhibition compared to RD and SH-
SY5Y cells (Fig. 4b). This would thus indicate that hESC-
derived NSC and MN could provide a more sensitive in
vitro model for screening of antiviral therapeutics, as
compared to cancer-derived cells lines such as RD and
SH-SY5Y cells.
Conclusions
In conclusion, our study successfully replicated previous
data on enteroviral infection of mice [42, 43] with in vitro
cultured human NSC and MN derived from hESC. This
thus demonstrates that hESC-derived NSC and MN can
be utilized for in vitro modelling of the pathogenesis of
neurotropic viruses such as EV71, as well as provide a
more sensitive in vitro tool for preliminary screening of
corresponding antiviral therapeutics, before progressing to
expensive and time-consuming live animal studies and hu-
man clinical trials. Additionally, our findings on the
greater susceptibility of NSC to EV71 infection compared
to MN, may also shed some light on why young children
are more prone to HFMD-associated neurological compli-
cations compared to adults [3, 4]; likely due to more
mitotically-active neural progenitor cells being present in
their central nervous system compared to adults.
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